SMS Lifesciences India has informed that the Board of Directors of the Company at its Meeting held today, November 10, 2025, have considered and approved the unaudited [Standalone & Consolidated] financial results for the quarter and half year ended September 30, 2025, as recommended by the Audit Committee. In this regard, the company has enclosed a copy of the following: 1) Unaudited financial results (Standalone & Consolidated) for the quarter and half year ended September 30,2025, along with limited review report. 2) Statement of Assets & Liabilities and Cash-flow statement. 3) Related Party Transactions for the half year ended September 30, 2025. The meeting of the Board commenced at 02.45 pm and concluded at 4.15 pm.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1652.00 |
| Dr. Reddys Lab | 1235.20 |
| Cipla | 1211.30 |
| Zydus Lifesciences | 923.10 |
| Lupin | 2312.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: